BIDMC researchers published study showing how an artificial intelligence tool could detect severe aortic stenosis with over 98 percent accuracy. Read more.

The AP/NP track is an ACGME accredited combined program that involves 2 years each of AP and NP training (4 years total). The AP/NP track makes the trainee eligible for combined AP and NP Board ...

The BIDMC Fellowship in Disaster Medicine is a 1-year program in which fellows develop an expertise in all aspects of Disaster Medicine through a robust, personalized didactic and field-based ...

Beth Israel Lahey Health, Inc. (the “Applicant”), with a principal place of business at 20 University Road, Suite 700, Cambridge, Massachusetts, intends to file a Notice of Determination of Need (“DoN ...

BIDMC researchers find that triple antibody therapy could replace ART therapy for long-lasting HIV control. Read more about this study.

Boston, MA—A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson’s disease was 76 percent higher among those with a history of damage to the ...

Laura Burke, MD, MPH, an emergency physician at Beth Israel Deaconess Medical Center (BIDMC), is at the forefront of research that intersects emergency medicine and public health. Recently, she was ...

Groundbreaking research led by psychiatrists at Beth Israel Deaconess Medical Center (BIDMC) revealed that the brain may hold crucial clues for detecting psychotic disorders—a class of mental ...

The first sign of trouble was his ankles. In the spring of 2023, Peter Elliston, an 82-year-old retired teacher and bookstore owner began to notice that his legs and ankles would significantly swell ...

Please fill out the form below if you would like to become a new patient, and a BIDMC representative will contact you during regular business hours to schedule your first appointment. The form below ...

Beth Israel Deaconess Medical Center (BIDMC) and its affiliated physician group, Harvard Medical Faculty Physicians (HMFP), announced in September 2023 plans to collaborate with Dana-Farber Cancer ...